drugset / Trial / NCT03202095
Creatine for Treatment of Depression Associated With Type 2 Diabetes
NaSingle-groupOpen-labelTreatment
Summary
The investigators hypothesize that the administration of a widely available, naturally occurring dietary supplement, creatine monohydrate, will reduce the severity of depression in individuals with type 2 diabetes. The purpose of this study is to determine whether 12 weeks of creatine supplementation is an effective treatment for depression in individuals with type 2 diabetes.
Timeline
- Start
- 2017-08-01
- Primary completion
- 2024-06-10
- Completion
- 2024-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Creatine | Other / unclassified | 5 g | Oral |